- Home
- LMFA vs CYCN Comparison
LMFA vs CYCN Comparison
Compare LMFA & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- CYCN
- Stock Information
- Founded
- LMFA 2008
- CYCN 2018
- Country
- LMFA United States
- CYCN United States
- Employees
- LMFA N/A
- CYCN N/A
- Industry
- LMFA Finance: Consumer Services
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- CYCN Health Care
- Exchange
- LMFA Nasdaq
- CYCN Nasdaq
- Market Cap
- LMFA 9.7M
- CYCN 8.4M
- IPO Year
- LMFA 2015
- CYCN N/A
- Fundamental
- Price
- LMFA $1.73
- CYCN $2.82
- Analyst Decision
- LMFA Hold
- CYCN
- Analyst Count
- LMFA 1
- CYCN 0
- Target Price
- LMFA N/A
- CYCN N/A
- AVG Volume (30 Days)
- LMFA 44.1K
- CYCN 5.8M
- Earning Date
- LMFA 03-31-2025
- CYCN 03-04-2025
- Dividend Yield
- LMFA N/A
- CYCN N/A
- EPS Growth
- LMFA N/A
- CYCN N/A
- EPS
- LMFA N/A
- CYCN N/A
- Revenue
- LMFA $12,838,084.00
- CYCN $194,000.00
- Revenue This Year
- LMFA N/A
- CYCN N/A
- Revenue Next Year
- LMFA N/A
- CYCN N/A
- P/E Ratio
- LMFA N/A
- CYCN N/A
- Revenue Growth
- LMFA 27.81
- CYCN N/A
- 52 Week Low
- LMFA $1.73
- CYCN $1.27
- 52 Week High
- LMFA $6.11
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- LMFA 36.37
- CYCN 43.92
- Support Level
- LMFA $1.85
- CYCN $2.89
- Resistance Level
- LMFA $1.98
- CYCN $4.80
- Average True Range (ATR)
- LMFA 0.13
- CYCN 0.66
- MACD
- LMFA 0.01
- CYCN -0.13
- Stochastic Oscillator
- LMFA 0.00
- CYCN 6.03
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.